Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ependymoma × brigatinib × Clear all

Sponsor

Conditions

Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma 2 ALK-positive Advanced NSCLC 2 Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Brain Neoplasms 1 Adenocarcinoma 1 ALK-positive NSCLC 1 ALK+ Advanced NSCLC 1

Interventions

Temozolomide 7 Magnetic Resonance Spectroscopy 5 Bevacizumab 5 X-Rays 4 Phantoms, Imaging 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Carboplatin 3 Lapatinib 2 Everolimus 2 Etoposide 2 Erlotinib Hydrochloride 2 Biopsy 2 veliparib 1 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 pomalidomide 1 poly ICLC 1 picropodophyllin 1 palbociclib 1 olaparib 1 marizomib 1 larotrectinib 1 imetelstat 1 erdafitinib 1 dinutuximab 1 bempegaldesleukin 1 antineoplaston AS 2-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡